The ethical drug company Novo Nordisk will report earnings on Wednesday, January 31. Analysts expect the company to report EPS of $0.67 on revenue of $8.7 billion. This article is for paid members - please login or subscribe for access. Username Password Remember Me Forgot Password Tags:$NVO Share: Mark W. Guthner, CFA Previous Post Economy & the Cost of Government BorrowingNext PostThe Week Ahead | 1/29/2024 You Might Also Like Trade Updated: Fifth Third Bank (FITB) July 25, 2019 Can the Insurance Industry Survive the Mother Nature’s 1 – 2 Punch? September 7, 2017 Let’s Talk About the Most Ignored Asset Among Fund Managers… The US Dollar April 27, 2018
You Might Also Like Trade Updated: Fifth Third Bank (FITB) July 25, 2019 Can the Insurance Industry Survive the Mother Nature’s 1 – 2 Punch? September 7, 2017 Let’s Talk About the Most Ignored Asset Among Fund Managers… The US Dollar April 27, 2018
